|
1.
|
Chen CZ: MicroRNAs as oncogenes and tumor
suppressors. N Engl J Med. 353:1768–1771. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Zhang B, Pan X, Cobb GP and Anderson TA:
microRNAs as oncogenes and tumor suppressors. Dev Biol. 302:1–12.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Huppi K, Volfovsky N, Mackiewicz M, et al:
MicroRNAs and genomic instability. Semin Cancer Biol. 17:65–73.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Kent OA and Mendell JT: A small piece in
the cancer puzzle: microRNAs as tumor suppressors and oncogenes.
Oncogene. 25:6188–6196. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Kumar MS, Lu J, Mercer KL, Golub TR and
Jacks T: Impaired microRNA processing enhances cellular
transformation and tumorigenesis. Nat Genet. 39:673–677. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Warnasulasuriya S: Global epidemiology of
oral and oropharyngeal cancer. Oral Oncol. 45:309–316. 2009.
View Article : Google Scholar
|
|
7.
|
Gomes CC and Gomez RS: MicroRNA and oral
cancer. Oral Oncol. 44:910–914. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Barnes L, Everson JW, Reichart P and
Sidransky D: WHO - World Health Organization Classification of
Tumours, Pathology and Genetics of Head and Neck Tumours. IARC
Press; Lyon: pp. 4332005
|
|
9.
|
Chen C, Ridzon DA, Broomer AJ, et al:
Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic
Acids Res. 33:1–9. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Livak KJ and Schimittgen T: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCt method. Methods. 25:402–408. 2001.
|
|
11.
|
Tran N, McLean T, Zhang X, et al: MicroRNA
expression profiles in head and neck cancer cell lines. Biochem
Biophys Res Commun. 358:12–17. 2007. View Article : Google Scholar
|
|
12.
|
Jiang J, Lee EJ, Gusev Y and Schimittgen
TD: Real-time expression profiling of microRNA precursors in human
cancer cell lines. Nucleic Acids Res. 33:5394–5403. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Gaur A, Jewell DA, Liang Y, et al:
Characterization of microRNA expression levels and their biological
correlates in human cancer cell lines. Cancer Res. 67:2456–2468.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Calin GA, Dumitru CD, Shimizu M, et al:
Frequent deletions and down-regulation of micro-RNA genes miR15 and
miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci
USA. 99:15524–15529. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Cimmino A, Calin GA, Fabbri M, et al:
miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl
Acad Sci USA. 102:13944–13949. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Camisasca DR, Honorato J, Bernardo V, et
al: Expression of Bcl-2 family proteins and associated
clinicopathologic factors predict survival outcome in patients with
oral squamous cell carcinoma. Oral Oncol. 45:225–233. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Ohigashi T, Ueno N, Novaka S, et al:
Tyrosine kinase inhibitors reduce bcl-2 expression and induce
apoptosis in androgen-dependent cells. Am J Physiol Cell Physiol.
278:C66–C72. 2000.PubMed/NCBI
|
|
18.
|
Ogawara K, Miyakawa A, Shiba M, et al:
Allelic loss of chromosome 13q14.3 in human oral cancer correlation
with lymph node metastasis. Int J Cancer. 79:312–317. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Takamizawa J, Konishi H, Yanagizawa K, et
al: Reduced expression of the let-7 microRNAs in human lung cancers
in association with shortened postoperative survival. Cancer Res.
64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Akao Y, Nakagawa Y and Naoe T: Let-7
microRNA functions as a potential growth suppressor in human colon
cancer cells. Biol Pharm Bull. 29:903–906. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Childs G, Fazzari M, Kung G, et al:
Low-level expression of microRNAs let-7d and mir-205 are prognostic
markers of head and neck squamous cell carcinoma. Am J Pathol.
174:736–745. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Chang KW, Liu CJ, Chu TH, et al:
Association between high mir-211 microRNA Expression and the poor
prognosis of oral carcinoma. J Dent Res. 87:1063–1068. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Johnson SM, Grosshans H, Shingara J, et
al: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Christensen BC, Moyer BJ, Avissar M, et
al: Let-7 microRNA binging site polymorphism in the KRAS 3′UTR is
associated with reduced survival in oral cancers. Carcinogenesis.
30:1003–1007. 2009.
|
|
25.
|
Perez-Ordoñez B, Beauchemin M and Jordan
RCK: Molecular biology of squamous cell carcinoma of the head and
neck. J Clin Pathol. 59:445–453. 2006.
|
|
26.
|
Hardisson D: Molecular pathogenesis of
head and neck squamous cell carcinoma. Head Neck Oncol.
260:502–508. 2003.PubMed/NCBI
|
|
27.
|
Das BR and Nagpal JK: Understanding the
biology of oral cancer. Med Sci Monit. 8:258–267. 2002.
|
|
28.
|
Fukasawa K: Centrosome amplification,
chromosome instability and cancer development. Cancer Lett.
230:6–19. 2005. View Article : Google Scholar
|
